Cronos Group (CRON)
(Delayed Data from NSDQ)
$2.16 USD
-0.04 (-1.82%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $2.15 -0.01 (-0.46%) 6:42 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.16 USD
-0.04 (-1.82%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $2.15 -0.01 (-0.46%) 6:42 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Zacks News
The Zacks Analyst Blog Highlights: Box, Vipshop, Pure Storage, MFA and Cronos
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Box, Vipshop, Pure Storage, MFA and Cronos
5 Cheap Stocks Trading Under $20 to Buy for 2020
by Benjamin Rains
Let's dive into five strong stocks currently trading for under $20 per share we found with our Zacks Stock Screener that investors might want to buy for 2020...
Ride the Cannabis Wave With These 3 Stocks
by Urmimala Biswas
Here we discuss three best stocks in the emerging cannabis space.
Is REX Shares' Leveraged Cannabis ETN Launch Untimely?
by Sanghamitra Saha
REX Shares has launched two cannabis-related ETNs, one among which is double leveraged. Is the launch untimely?
Company News For Nov 22, 2019
by Zacks Equity Research
Companies in the news are: AMTD, M, CRON, GM
Marijuana ETFs Bounce Back: Can the Rally Last?
by Sanghamitra Saha
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
What's in the Cards for OrganiGram (OGI) in Q4 Earnings?
by Zacks Equity Research
According to OrganiGram (OGI), there is hugely unmet consumer demand for CBD products.
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Cronos (CRON) Catches Eye: Stock Jumps 9.1%
by Zacks Equity Research
Cronos (CRON) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Why Marijuana Stocks Plummeted in 2019
by Madeleine Johnson
Marijuana stocks were on a tear last year, but 2019 has sent stock tumbling back down to Earth. What happened?
Trump Trade, Walmart & Nvidia Previews & Buy CASY Stock - Free Lunch
by Benjamin Rains
All eyes will be on President Trump Tuesday for U.S.-China trade war updates. Walmart, Nvidia, and others are set to report their quarterly earnings. And why Casey's General Stores (CASY) is a Zacks Rank #1 (Strong Buy) right now...
Cronos Group (CRON) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Cronos (CRON) delivered earnings and revenue surprises of 33.33% and -3.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
5 Trendy Earnings Charts
by Tracey Ryniec
Are cannabis and solar stocks still the place to be for traders in 2019?
U.S.-China Trade Progress, Q3 Earnings Results & Buy Yeti Stock - Free Lunch
by Benjamin Rains
The latest U.S.-China trade war news that could see the world's two largest economies roll back tariffs. Q3 earnings results from the likes of Qualcomm and Square. And why Yeti is a Zacks Rank #1 (Strong Buy) stock...
Cronos (CRON) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on Cronos' (CRON) regular top and bottom-line numbers along with its pipeline progress, when it reports Q3 results.
Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?
by Benjamin Rains
Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?
4 Highly-Ranked Cheap Stocks Trading Under $10 to Buy Right Now
by Benjamin Rains
Today we highlighted 4 'cheap' stocks that are currently trading for under $10 per share that also sport a Zacks Rank #2 (Buy) or better that investors might want to consider buying right now...
Cronos Group (CRON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: BRF, Hewlett Packard, Luckin Coffee, Cronos Group and Pure Storage
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BRF, Hewlett Packard, Luckin Coffee, Cronos Group and Pure Storage
5 Top-Ranked Cheap Stocks Trading Under $20 to Buy Right Now
by Benjamin Rains
Today we found 5 cheap stocks currently trading for under $20 per share using our Zacks Stock Screener that investors might want to buy heading into November...
Will Pricing be an Upside for Altria (MO) in Q3 Earnings?
by Zacks Equity Research
Gains from pricing and savings efforts are likely to be reflected on Altria's (MO) Q3 results. However, receding cigarette sales volumes are a concern.
Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Cronos Group (CRON) closed at $7.85 in the latest trading session, marking a -1.32% move from the prior day.
Stocks Jump on Trump Trade Tweet, Q3 Earnings and Buy Marijuana Stocks - Free Lunch
by Benjamin Rains
U.S.-China trade war updates, including President Trump's tweet that helped U.S. stocks climb Thursday. A look at the ongoing fight between the NBA and China, some Q3 earnings results next week, and why marijuana stock Cronos looks like a buy - Free Lunch
Stocks Fall on U.S. Blacklist, China & the NBA and Buy Roku - Free Lunch
by Benjamin Rains
A look at the new U.S. blacklist on nearly 30 Chinese companies and how it might impact the upcoming trade talks. A dive into the dispute between the NBA and China, marijuana stocks, and why Roku is a Zacks Rank #1 (Strong Buy) - Free Lunch
Cronos Group (CRON) Stock Moves -0.99%: What You Should Know
by Zacks Equity Research
Cronos Group (CRON) closed the most recent trading day at $8.96, moving -0.99% from the previous trading session.